Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a developer and commercial supply of a diversified portfolio of advanced drug delivery systems. We serve as a partner to pharmaceutical and biotechnology companies seeking to optimize drug lifecycles and generate brand differentiation within competitive therapeutic markets. Our proprietary technology platforms include prefilled syringes with integrated safety features, patient self-injection systems and novel devices for targeted organ delivery. The Unifill syringe, the world's first and only ready-to-fill syringe with integrated safety features, sits at the leading edge of this unique technology platform of primary containers that is suitable for use with virtually all prefilled drugs supplied in either a liquid stable form or lyophilized for reconstitution. Additional variants within the Unifill range of prefilled syringes include the Unifill Select with attachable needles, and the Unifill EZMix available in dual or multi-chamber formats.